Prevalence and main indicators of the combination of resistant tuberculosis and diabetes mellitus

L. Todoriko, I. Semianiv
{"title":"Prevalence and main indicators of the combination of resistant tuberculosis and diabetes mellitus","authors":"L. Todoriko, I. Semianiv","doi":"10.32902/2663-0338-2021-2.1-24","DOIUrl":null,"url":null,"abstract":"Background. Diabetes is the background for the development of tuberculosis (TB) and such comorbidity not only significantly complicates the specific process, but also is one of the main risk factors for TB recurrence. \nObjective. The aim of the study is a comprehensive retrospective assessment of the combination of TB and diabetes. \nMaterials and methods. Our study is based on an analysis of statistical data obtained from a retrospective study of 762 case histories. \nResults. Depending on the type of TB case in our patients, we found that in both groups of the study the recurrence of TB prevailed – 49 cases (55.7 %) against 39 cases (44.3 %) of people in the main group; 363 cases (53.9 %) against 311 (46.1 %) in the control group (p<0.05). The rate of successful treatment in group 2 is probably higher than in group 1 (64.7 % vs. 61.4 %). However, a more significant probable difference is characterized by the treatment rate, which in the main group is 27.3 % vs 40.3 % in the control group (almost 2 times). The rate of ineffective treatment, which in patients with comorbidity was 27.3 % (almost every third patient) against 17.6 % in group 2 is also important for scientists and practitioners. \nConclusions. The pulmonary TB developed significantly more often in middle-aged patients with type 2 diabetes mellitus with moderate and severe states, the subcompensated form, with a complicated course. In patients with diabetes more often was registered a common tuberculous process in the lungs and in all 100 % of patients with syntropy bacterial excretion was registered.","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusion & Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32902/2663-0338-2021-2.1-24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background. Diabetes is the background for the development of tuberculosis (TB) and such comorbidity not only significantly complicates the specific process, but also is one of the main risk factors for TB recurrence. Objective. The aim of the study is a comprehensive retrospective assessment of the combination of TB and diabetes. Materials and methods. Our study is based on an analysis of statistical data obtained from a retrospective study of 762 case histories. Results. Depending on the type of TB case in our patients, we found that in both groups of the study the recurrence of TB prevailed – 49 cases (55.7 %) against 39 cases (44.3 %) of people in the main group; 363 cases (53.9 %) against 311 (46.1 %) in the control group (p<0.05). The rate of successful treatment in group 2 is probably higher than in group 1 (64.7 % vs. 61.4 %). However, a more significant probable difference is characterized by the treatment rate, which in the main group is 27.3 % vs 40.3 % in the control group (almost 2 times). The rate of ineffective treatment, which in patients with comorbidity was 27.3 % (almost every third patient) against 17.6 % in group 2 is also important for scientists and practitioners. Conclusions. The pulmonary TB developed significantly more often in middle-aged patients with type 2 diabetes mellitus with moderate and severe states, the subcompensated form, with a complicated course. In patients with diabetes more often was registered a common tuberculous process in the lungs and in all 100 % of patients with syntropy bacterial excretion was registered.
耐药结核与糖尿病合并的患病率及主要指标
背景。糖尿病是结核病发生的背景,这种合并症不仅使结核病的具体过程显著复杂化,而且是结核病复发的主要危险因素之一。目标。该研究的目的是对结核病和糖尿病合并进行全面的回顾性评估。材料和方法。我们的研究是基于对762例回顾性研究的统计数据的分析。结果。根据患者结核病病例的类型,我们发现在研究的两组中,结核病的复发率普遍存在——49例(55.7%)对主要组的39例(44.3%);363例(53.9%),对照组311例(46.1%)(p<0.05)。2组治疗成功率明显高于1组(64.7% vs. 61.4%)。然而,更显著的可能差异表现在治疗率上,主组为27.3%,对照组为40.3%(几乎是2倍)。治疗无效的比率,在有合并症的患者中为27.3%(几乎每三名患者中就有一例),而在第二组中为17.6%,这对科学家和从业人员来说也很重要。结论。中年2型糖尿病患者中、重度伴发肺结核的发生率较高,为亚代偿型,病程复杂。在糖尿病患者中,更常记录到肺部常见的结核过程,所有患者中100%记录到共生性细菌排泄。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信